Grace Tso

Ms. Tso’s practice focuses on cross-border mergers and acquisitions for foreign investors and foreign direct investment into China and Hong Kong. She also advises multinational companies on the planning and implementation of multi-country corporate restructuring projects.

Reorganization / Carve-out

• Advised Abbott Laboratories in the spin-off of its research-based pharmaceutical business and the formation of a new publicly-traded biopharmaceutical company, AbbVie Inc.

• Advised Baxter International on its USD 21 billion spinoff of its biopharmaceutical division (now Baxalta) in China and Hong Kong.

• Acted for Emerson Electric Co. in the China and Hong Kong portions of the USD 4 billion sale of its Network Power business to Platinum Equity and the pre-spin off restructuring.

• Acted for Emerson Electric Co. in the China and Hong Kong portions of the USD 1.2 billion sale of its Leroy-Somer and Control Techniques business units to Nidec Corporation and the pre-spin off restructuring.

• Acted for Johnson Controls in carve-out of automotive seating business (now Adient).

• Acted for a top telecommunication company listed in Helsinki in its post-acquisition integration involving 15 Asian countries.

• Advised a Fortune 500 company on the worldwide integration of its energy system business.

• Assisted a Japanese pharmaceuticals company in its postacquisition integration involving multiple Asian countries.

M&A

• Advised METRO AG on the establishment of a strategic partnership with Wumei Technology Group (Wumei), a leading retailer in China involving the sale of its entire stake in METRO China for EUR 1.9 billion to an investment vehicle of Wumei against cash and a 20% stake in the resulting joint venture.

• Acted for AkzoNobel in its buy-out of its decorative paint business in Hong Kong and China from Swire Industrial Limited.

• Law Society of Hong Kong

• Chicago